ArticleAmerican journal of nuclear medicine and molecular imaging2025

Streamlining first-in-human PET radiopharmaceutical development: FDA's evolving stance on preclinical dosimetry.

Taoqian Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.